CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Cytovale
Cytovale logo

Cytovale

Cytovale Inc., a San Francisco-based R&D firm, innovates in microfluidic platforms to detect disease signatures.

San Francisco, CA, US🇺🇸
Founded
2013
Overview
M & A
Compare
Fundraising
Employees
Library

Cytovale Inc., founded in San Francisco, focuses on pioneering medical diagnostics through innovative microfluidic platforms. Their core mission is to revolutionize disease detection by quantifying mechanical signatures of individual cells, with a particular emphasis on fast-moving diseases like sepsis. Their flagship product, IntelliSep, is designed to provide rapid and reliable diagnostics in emergency departments, aiming to improve patient outcomes and streamline healthcare processes.

Notable figures affiliated with Cytovale include a team of experienced leaders in biotechnology and medical diagnostics. The company has garnered significant attention and investment from key players in the healthcare industry. A major achievement for Cytovale is the FDA clearance of IntelliSep, marking it as the first in a new class of diagnostic tools focused on emergency settings. This milestone underscores Cytovale's impact on enhancing diagnostic accuracy and speed, ultimately contributing to better healthcare delivery.

Cytovale - M & A Snapshot

Open M & A

  • Sepsis Scout

    Acquired by Cytovale • Undisclosed • Oct 23, 2024

Cytovale - Products & Services

  • IntelliSep logo

    IntelliSep

    Rapid host-response blood test that stratifies sepsis risk in emergency departments within about eight minutes.

    Competing Products

    Inflammatix logo

Cytovale - Similar Companies

BioFluidica logo

BioFluidica

biofluidica.com

CytoMag logo

CytoMag

Techcyte logo

Techcyte

techcyte.com

Inflammatix logo

Inflammatix

inflammatix.com

Alveo Technologies logo

Alveo Technologies

BioCeryx logo

BioCeryx

Charlot Biosciences logo

Charlot Biosciences

cbio.io

Savran Technologies logo

Savran Technologies

savrantech.com

Cue Health logo

Cue Health

cuehealth.com

Opticyte logo

Opticyte

opticyte.com

Delee logo

Delee

delee.co

CytoRecovery logo

CytoRecovery

cytorecovery.com

Chronus Health logo

Chronus Health

Vail Scientific logo

Vail Scientific

vailscientific.com

InterVenn Biosciences logo

InterVenn Biosciences

intervenn.com

Cytovale - Quick Facts

Who are Cytovale's competitors?

Companies similar to Cytovale include BioFluidica, CytoMag, Techcyte and Inflammatix.

When was Cytovale founded?

Cytovale was founded in 2013.

Where is Cytovale's headquarters located?

Cytovale's headquarters is located in San Francisco, CA, US.

When was Cytovale's last funding round?

Cytovale's most recent funding round was for $84M (USD) in November 2023.

How much disclosed funding has Cytovale raised?

As of Nov 15, 2023, Cytovale has disclosed funding of $128.6M (USD). Undisclosed round amounts are excluded.

How many employees does Cytovale have?

Cytovale has 91 employees as of Feb 5, 2024.

Cytovale - Classification

Ownership
  • Venture-backed
Technology
  • Biotech
  • Microfluidics
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 16 more industry codes
NAICS
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified